Aortica said it raised $7 million in a Series A round for development of its treatment for abdominal aortic aneurysms and named a medtech veteran as its new CEO.
Aortica said medtech veteran Tom Douthitt will helm the corner office, with co-founder Dr. Ben Starnes serving as chief medical officer.
EndoShape is in the process of raising $6.8 million in the latest reported funding round for the minimally invasive vessel occlusion devices maker.
Lombard Medical Technologies (LON:LMT) said yesterday that it could raise up to $80 million in its debut on the U.S. stock market.
Reverse Medical secured European CE Mark approval for its UNO neurovascular embolization system, for obstructing blood flow in the blood vessels of the brain. The device also notched initial clinical use for intracranial specification.
Boston Scientific (NYSE:BSX) launched its OffRoad re-entry catheters, marketing them to treat complete arterial blockages in the major arteries of the legs.
W.L. Gore & Associates enrolled the 1st patient in its U.S. Gore TAG thoracic branch endoprosthesis LSA feasibility study in hopes of landing FDA approval for treatment of thoracic aortic aneurysms in the left subclavian artery.
Cordis Corp, a Johnson & Johnson (NYSE:JNJ) subsidiary, released 2-year data from its INNOVATION trial testing the safety and performance of the Incraft abdominal aortic aneurysm stent graft system.
Intact Vascular said it’s launching a multi-center pilot study for its Tack-It endovascular system for treating peripheral artery disease.
The trial, TOBA-BTK, is designed to gather data supporting the safety and performance of the Tack-It system in subjects with critical limb ischemia due to vascular disease below the knee.
MassDevice Network
@MassDevice
LinkedIn
YouTube